Aerin Medical

Aerin Medical is a private, commercial-stage medical device company founded in 2014 and headquartered in Sunnyvale, California. The company has developed a proprietary console-based platform that delivers precise, temperature-controlled radiofrequency energy via single-use styluses to treat the underlying causes of nasal airway obstruction and chronic rhinitis in an office setting. With over 200,000 patients treated, Aerin is establishing a new standard of care for these prevalent ENT conditions by offering effective, non-surgical alternatives. The company is revenue-generating, targeting a massive US patient population exceeding 110 million sufferers of NAO and rhinitis.

Proprietary touch-screen console delivering precise, temperature-controlled radiofrequency (RF) energy via single-use styluses (VivAer, RhinAer) for non-invasive, tissue-sparing treatment of nasal anatomy and nerves.

Aerin competes in the ENT device space, primarily against traditional surgical tools and techniques (e.g., septoplasty, turbinate reduction). It also faces competition from other companies developing minimally invasive or office-based solutions for nasal obstruction and rhinitis, such as those using cryotherapy, microwave ablation, or other RF technologies.